Global Heart Transplantation Therapeutics Market 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	252 Pages	TechNavio	February, 2025	INF19659127

Best Price Guarantee
Price	from $2,500
Length	252 Pages
Publisher	TechNavio
Published Date	February, 2025
SKU	INF19659127

Heart Transplantation Therapeutics Market 2025-2029

The heart transplantation therapeutics market is forecasted to grow by USD 129.7 million during 2024-2029, accelerating at a CAGR of 3% during the forecast period. The report on the heart transplantation therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of cardiovascular diseases and heart failures, availability of drugs in multiple dosage forms, and high dependency on immunosuppressants for heart transplantation.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's heart transplantation therapeutics market is segmented as below:

By Drug Class

Immunosuppressants
Anti-infectives
Analgesics
Others

By Distribution Channel

Hospital pharmacies
Retail pharmacies
Online pharmacies

By Type

Left ventricular assist device (LVAD)
Heart transplantation
Implantable cardiac defibrillator (ICD)
Extracorporeal membrane oxygenation (ECMO)

By Indication

Ischemic heart disease (IHD)
Dilated cardiomyopathy (DCM)
Valvular heart disease (VHD)
Hypertrophic cardiomyopathy (HCM)

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing international collaborations for heart transplantation as one of the prime reasons driving the heart transplantation therapeutics market growth during the next few years. Also, advent of techniques for heart transplantation and growing awareness and accessibility regarding heart transplantation will lead to sizable demand in the market.

The report on the heart transplantation therapeutics market covers the following areas:

Heart Transplantation Therapeutics Market sizing
Heart Transplantation Therapeutics Market forecast
Heart Transplantation Therapeutics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading heart transplantation therapeutics market vendors that include AbbVie Inc., Astellas Pharma Inc., Biocon Ltd., DR Reddys Laboratories Ltd., Endo International PLC, F. Hoffmann La Roche Ltd., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Jubilant Pharmova Ltd., LEO Pharma AS, Lupin Ltd., McKesson Corp., Novartis AG, Panacea Biotec Ltd., Pfizer Inc., RPG Enterprises, Strides Pharma Science Ltd., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.. Also, the heart transplantation therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Drug Class; Executive Summary - Chart on Market Segmentation by Distribution Channel; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Market Segmentation by Indication; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on Global - Market size and forecast 2024-2029 ($ million); Data Table on Global - Market size and forecast 2024-2029 ($ million); Chart on Global Market: Year-over-year growth 2024-2029 (%); Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Global Heart Transplantation Therapeutics Market 2019 - 2023; Historic Market Size - Data Table on Global Heart Transplantation Therapeutics Market 2019 - 2023 ($ million); 5.2 Drug Class segment analysis 2019 - 2023; Historic Market Size - Drug Class Segment 2019 - 2023 ($ million); 5.3 Distribution Channel segment analysis 2019 - 2023; Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million); 5.4 Type segment analysis 2019 - 2023; Historic Market Size - Type Segment 2019 - 2023 ($ million); 5.5 Indication segment analysis 2019 - 2023; Historic Market Size - Indication Segment 2019 - 2023 ($ million); 5.6 Geography segment analysis 2019 - 2023; Historic Market Size - Geography Segment 2019 - 2023 ($ million); 5.7 Country segment analysis 2019 - 2023; Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis: 6.1 Impact of AI in global heart transplantation therapeutics market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Drug Class: 8.1 Market segments; Chart on Drug Class - Market share 2024-2029 (%); Data Table on Drug Class - Market share 2024-2029 (%); 8.2 Comparison by Drug Class; Chart on Comparison by Drug Class; Data Table on Comparison by Drug Class; 8.3 Immunosuppressants - Market size and forecast 2024-2029; Chart on Immunosuppressants - Market size and forecast 2024-2029 ($ million); Data Table on Immunosuppressants - Market size and forecast 2024-2029 ($ million); Chart on Immunosuppressants - Year-over-year growth 2024-2029 (%); Data Table on Immunosuppressants - Year-over-year growth 2024-2029 (%); 8.4 Anti-infectives - Market size and forecast 2024-2029; Chart on Anti-infectives - Market size and forecast 2024-2029 ($ million); Data Table on Anti-infectives - Market size and forecast 2024-2029 ($ million); Chart on Anti-infectives - Year-over-year growth 2024-2029 (%); Data Table on Anti-infectives - Year-over-year growth 2024-2029 (%); 8.5 Analgesics - Market size and forecast 2024-2029; Chart on Analgesics - Market size and forecast 2024-2029 ($ million); Data Table on Analgesics - Market size and forecast 2024-2029 ($ million); Chart on Analgesics - Year-over-year growth 2024-2029 (%); Data Table on Analgesics - Year-over-year growth 2024-2029 (%); 8.6 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ million); Data Table on Others - Market size and forecast 2024-2029 ($ million); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 8.7 Market opportunity by Drug Class; Market opportunity by Drug Class ($ million); Data Table on Market opportunity by Drug Class ($ million)
9 Market Segmentation by Distribution Channel: 9.1 Market segments; Chart on Distribution Channel - Market share 2024-2029 (%); Data Table on Distribution Channel - Market share 2024-2029 (%); 9.2 Comparison by Distribution Channel; Chart on Comparison by Distribution Channel; Data Table on Comparison by Distribution Channel; 9.3 Hospital pharmacies - Market size and forecast 2024-2029; Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million); Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million); Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%); Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%); 9.4 Retail pharmacies - Market size and forecast 2024-2029; Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million); Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million); Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%); Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%); 9.5 Online pharmacies - Market size and forecast 2024-2029; Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million); Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million); Chart on Online pharmacies - Year-over-year growth 2024-2029 (%); Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%); 9.6 Market opportunity by Distribution Channel; Market opportunity by Distribution Channel ($ million); Data Table on Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Type: 10.1 Market segments; Chart on Type - Market share 2024-2029 (%); Data Table on Type - Market share 2024-2029 (%); 10.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 10.3 Left ventricular assist device (LVAD) - Market size and forecast 2024-2029; Chart on Left ventricular assist device (LVAD) - Market size and forecast 2024-2029 ($ million); Data Table on Left ventricular assist device (LVAD) - Market size and forecast 2024-2029 ($ million); Chart on Left ventricular assist device (LVAD) - Year-over-year growth 2024-2029 (%); Data Table on Left ventricular assist device (LVAD) - Year-over-year growth 2024-2029 (%); 10.4 Heart transplantation - Market size and forecast 2024-2029; Chart on Heart transplantation - Market size and forecast 2024-2029 ($ million); Data Table on Heart transplantation - Market size and forecast 2024-2029 ($ million); Chart on Heart transplantation - Year-over-year growth 2024-2029 (%); Data Table on Heart transplantation - Year-over-year growth 2024-2029 (%); 10.5 Implantable cardiac defibrillator (ICD) - Market size and forecast 2024-2029; Chart on Implantable cardiac defibrillator (ICD) - Market size and forecast 2024-2029 ($ million); Data Table on Implantable cardiac defibrillator (ICD) - Market size and forecast 2024-2029 ($ million); Chart on Implantable cardiac defibrillator (ICD) - Year-over-year growth 2024-2029 (%); Data Table on Implantable cardiac defibrillator (ICD) - Year-over-year growth 2024-2029 (%); 10.6 Extracorporeal membrane oxygenation (ECMO) - Market size and forecast 2024-2029; Chart on Extracorporeal membrane oxygenation (ECMO) - Market size and forecast 2024-2029 ($ million); Data Table on Extracorporeal membrane oxygenation (ECMO) - Market size and forecast 2024-2029 ($ million); Chart on Extracorporeal membrane oxygenation (ECMO) - Year-over-year growth 2024-2029 (%); Data Table on Extracorporeal membrane oxygenation (ECMO) - Year-over-year growth 2024-2029 (%); 10.7 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
11 Market Segmentation by Indication: 11.1 Market segments; Chart on Indication - Market share 2024-2029 (%); Data Table on Indication - Market share 2024-2029 (%); 11.2 Comparison by Indication; Chart on Comparison by Indication; Data Table on Comparison by Indication; 11.3 Ischemic heart disease (IHD) - Market size and forecast 2024-2029; Chart on Ischemic heart disease (IHD) - Market size and forecast 2024-2029 ($ million); Data Table on Ischemic heart disease (IHD) - Market size and forecast 2024-2029 ($ million); Chart on Ischemic heart disease (IHD) - Year-over-year growth 2024-2029 (%); Data Table on Ischemic heart disease (IHD) - Year-over-year growth 2024-2029 (%); 11.4 Dilated cardiomyopathy (DCM) - Market size and forecast 2024-2029; Chart on Dilated cardiomyopathy (DCM) - Market size and forecast 2024-2029 ($ million); Data Table on Dilated cardiomyopathy (DCM) - Market size and forecast 2024-2029 ($ million); Chart on Dilated cardiomyopathy (DCM) - Year-over-year growth 2024-2029 (%); Data Table on Dilated cardiomyopathy (DCM) - Year-over-year growth 2024-2029 (%); 11.5 Valvular heart disease (VHD) - Market size and forecast 2024-2029; Chart on Valvular heart disease (VHD) - Market size and forecast 2024-2029 ($ million); Data Table on Valvular heart disease (VHD) - Market size and forecast 2024-2029 ($ million); Chart on Valvular heart disease (VHD) - Year-over-year growth 2024-2029 (%); Data Table on Valvular heart disease (VHD) - Year-over-year growth 2024-2029 (%); 11.6 Hypertrophic cardiomyopathy (HCM) - Market size and forecast 2024-2029; Chart on Hypertrophic cardiomyopathy (HCM) - Market size and forecast 2024-2029 ($ million); Data Table on Hypertrophic cardiomyopathy (HCM) - Market size and forecast 2024-2029 ($ million); Chart on Hypertrophic cardiomyopathy (HCM) - Year-over-year growth 2024-2029 (%); Data Table on Hypertrophic cardiomyopathy (HCM) - Year-over-year growth 2024-2029 (%); 11.7 Market opportunity by Indication; Market opportunity by Indication ($ million); Data Table on Market opportunity by Indication ($ million)
12 Customer Landscape: 12.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape: 13.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2024-2029 (%); Data Table on Market share By Geographical Landscape 2024-2029 (%); 13.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 13.3 North America - Market size and forecast 2024-2029; Chart on North America - Market size and forecast 2024-2029 ($ million); Data Table on North America - Market size and forecast 2024-2029 ($ million); Chart on North America - Year-over-year growth 2024-2029 (%); Data Table on North America - Year-over-year growth 2024-2029 (%); 13.4 Europe - Market size and forecast 2024-2029; Chart on Europe - Market size and forecast 2024-2029 ($ million); Data Table on Europe - Market size and forecast 2024-2029 ($ million); Chart on Europe - Year-over-year growth 2024-2029 (%); Data Table on Europe - Year-over-year growth 2024-2029 (%); 13.5 Asia - Market size and forecast 2024-2029; Chart on Asia - Market size and forecast 2024-2029 ($ million); Data Table on Asia - Market size and forecast 2024-2029 ($ million); Chart on Asia - Year-over-year growth 2024-2029 (%); Data Table on Asia - Year-over-year growth 2024-2029 (%); 13.6 Rest of World (ROW) - Market size and forecast 2024-2029; Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); 13.7 US - Market size and forecast 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ million); Data Table on US - Market size and forecast 2024-2029 ($ million); Chart on US - Year-over-year growth 2024-2029 (%); Data Table on US - Year-over-year growth 2024-2029 (%); 13.8 Germany - Market size and forecast 2024-2029; Chart on Germany - Market size and forecast 2024-2029 ($ million); Data Table on Germany - Market size and forecast 2024-2029 ($ million); Chart on Germany - Year-over-year growth 2024-2029 (%); Data Table on Germany - Year-over-year growth 2024-2029 (%); 13.9 Canada - Market size and forecast 2024-2029; Chart on Canada - Market size and forecast 2024-2029 ($ million); Data Table on Canada - Market size and forecast 2024-2029 ($ million); Chart on Canada - Year-over-year growth 2024-2029 (%); Data Table on Canada - Year-over-year growth 2024-2029 (%); 13.10 France - Market size and forecast 2024-2029; Chart on France - Market size and forecast 2024-2029 ($ million); Data Table on France - Market size and forecast 2024-2029 ($ million); Chart on France - Year-over-year growth 2024-2029 (%); Data Table on France - Year-over-year growth 2024-2029 (%); 13.11 Japan - Market size and forecast 2024-2029; Chart on Japan - Market size and forecast 2024-2029 ($ million); Data Table on Japan - Market size and forecast 2024-2029 ($ million); Chart on Japan - Year-over-year growth 2024-2029 (%); Data Table on Japan - Year-over-year growth 2024-2029 (%); 13.12 UK - Market size and forecast 2024-2029; Chart on UK - Market size and forecast 2024-2029 ($ million); Data Table on UK - Market size and forecast 2024-2029 ($ million); Chart on UK - Year-over-year growth 2024-2029 (%); Data Table on UK - Year-over-year growth 2024-2029 (%); 13.13 India - Market size and forecast 2024-2029; Chart on India - Market size and forecast 2024-2029 ($ million); Data Table on India - Market size and forecast 2024-2029 ($ million); Chart on India - Year-over-year growth 2024-2029 (%); Data Table on India - Year-over-year growth 2024-2029 (%); 13.14 China - Market size and forecast 2024-2029; Chart on China - Market size and forecast 2024-2029 ($ million); Data Table on China - Market size and forecast 2024-2029 ($ million); Chart on China - Year-over-year growth 2024-2029 (%); Data Table on China - Year-over-year growth 2024-2029 (%); 13.15 South Korea - Market size and forecast 2024-2029; Chart on South Korea - Market size and forecast 2024-2029 ($ million); Data Table on South Korea - Market size and forecast 2024-2029 ($ million); Chart on South Korea - Year-over-year growth 2024-2029 (%); Data Table on South Korea - Year-over-year growth 2024-2029 (%); 13.16 Italy - Market size and forecast 2024-2029; Chart on Italy - Market size and forecast 2024-2029 ($ million); Data Table on Italy - Market size and forecast 2024-2029 ($ million); Chart on Italy - Year-over-year growth 2024-2029 (%); Data Table on Italy - Year-over-year growth 2024-2029 (%); 13.17 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
14 Drivers, Challenges, and Opportunity/Restraints: 14.1 Market drivers; 14.2 Market challenges; 14.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 14.4 Market opportunities/restraints
15 Competitive Landscape: 15.1 Overview; 15.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 15.3 Landscape disruption; Overview on factors of disruption; 15.4 Industry risks; Impact of key risks on business
16 Competitive Analysis: 16.1 Companies profiled; Companies covered; 16.2 Company ranking index; Company ranking index; 16.3 Market positioning of companies; Matrix on companies position and classification; 16.4 AbbVie Inc.; AbbVie Inc. - Overview; AbbVie Inc. - Product / Service; AbbVie Inc. - Key news; AbbVie Inc. - Key offerings; SWOT; 16.5 Astellas Pharma Inc.; Astellas Pharma Inc. - Overview; Astellas Pharma Inc. - Product / Service; Astellas Pharma Inc. - Key offerings; SWOT; 16.6 Biocon Ltd.; Biocon Ltd. - Overview; Biocon Ltd. - Business segments; Biocon Ltd. - Key offerings; Biocon Ltd. - Segment focus; SWOT; 16.7 Dr Reddys Laboratories Ltd.; Dr Reddys Laboratories Ltd. - Overview; Dr Reddys Laboratories Ltd. - Business segments; Dr Reddys Laboratories Ltd. - Key news; Dr Reddys Laboratories Ltd. - Key offerings; Dr Reddys Laboratories Ltd. - Segment focus; SWOT; 16.8 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; SWOT; 16.9 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; SWOT; 16.10 Glenmark Pharmaceuticals Ltd.; Glenmark Pharmaceuticals Ltd. - Overview; Glenmark Pharmaceuticals Ltd. - Product / Service; Glenmark Pharmaceuticals Ltd. - Key offerings; SWOT; 16.11 Intas Pharmaceuticals Ltd.; Intas Pharmaceuticals Ltd. - Overview; Intas Pharmaceuticals Ltd. - Product / Service; Intas Pharmaceuticals Ltd. - Key offerings; SWOT; 16.12 LEO Pharma AS; LEO Pharma AS - Overview; LEO Pharma AS - Product / Service; LEO Pharma AS - Key offerings; SWOT; 16.13 Lupin Ltd.; Lupin Ltd. - Overview; Lupin Ltd. - Business segments; Lupin Ltd. - Key news; Lupin Ltd. - Key offerings; Lupin Ltd. - Segment focus; SWOT; 16.14 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; SWOT; 16.15 Panacea Biotec Ltd.; Panacea Biotec Ltd. - Overview; Panacea Biotec Ltd. - Product / Service; Panacea Biotec Ltd. - Key news; Panacea Biotec Ltd. - Key offerings; SWOT; 16.16 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; SWOT; 16.17 Sun Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd. - Overview; Sun Pharmaceutical Industries Ltd. - Product / Service; Sun Pharmaceutical Industries Ltd. - Key news; Sun Pharmaceutical Industries Ltd. - Key offerings; SWOT; 16.18 Teva Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd. - Overview; Teva Pharmaceutical Industries Ltd. - Business segments; Teva Pharmaceutical Industries Ltd. - Key news; Teva Pharmaceutical Industries Ltd. - Key offerings; Teva Pharmaceutical Industries Ltd. - Segment focus; SWOT
17 Appendix: 17.1 Scope of the report; 17.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 17.3 Currency conversion rates for US$; Currency conversion rates for US$; 17.4 Research methodology; Research methodology; 17.5 Data procurement; Information sources; 17.6 Data validation; Data validation; 17.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 17.8 Data synthesis; Data synthesis; 17.9 360 degree market analysis; 360 degree market analysis; 17.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Drug Class; Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits7: Executive Summary - Chart on Market Segmentation by Type; Exhibits8: Executive Summary - Chart on Market Segmentation by Indication; Exhibits9: Executive Summary - Chart on Incremental Growth; Exhibits10: Executive Summary - Data Table on Incremental Growth; Exhibits11: Executive Summary - Chart on Company Market Positioning; Exhibits12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits13: Overview on criticality of inputs and factors of differentiation; Exhibits14: Overview on factors of disruption; Exhibits15: Impact of drivers and challenges in 2024 and 2029; Exhibits16: Parent Market; Exhibits17: Data Table on - Parent Market; Exhibits18: Market characteristics analysis; Exhibits19: Value chain analysis; Exhibits20: Offerings of companies included in the market definition; Exhibits21: Market segments; Exhibits22: Chart on Global - Market size and forecast 2024-2029 ($ million); Exhibits23: Data Table on Global - Market size and forecast 2024-2029 ($ million); Exhibits24: Chart on Global Market: Year-over-year growth 2024-2029 (%); Exhibits25: Data Table on Global Market: Year-over-year growth 2024-2029 (%); Exhibits26: Historic Market Size - Data Table on Global Heart Transplantation Therapeutics Market 2019 - 2023 ($ million); Exhibits27: Historic Market Size - Drug Class Segment 2019 - 2023 ($ million); Exhibits28: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million); Exhibits29: Historic Market Size - Type Segment 2019 - 2023 ($ million); Exhibits30: Historic Market Size - Indication Segment 2019 - 2023 ($ million); Exhibits31: Historic Market Size - Geography Segment 2019 - 2023 ($ million); Exhibits32: Historic Market Size - Country Segment 2019 - 2023 ($ million); Exhibits33: Five forces analysis - Comparison between 2024 and 2029; Exhibits34: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits35: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits36: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits37: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits38: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits39: Chart on Market condition - Five forces 2024 and 2029; Exhibits40: Chart on Drug Class - Market share 2024-2029 (%); Exhibits41: Data Table on Drug Class - Market share 2024-2029 (%); Exhibits42: Chart on Comparison by Drug Class; Exhibits43: Data Table on Comparison by Drug Class; Exhibits44: Chart on Immunosuppressants - Market size and forecast 2024-2029 ($ million); Exhibits45: Data Table on Immunosuppressants - Market size and forecast 2024-2029 ($ million); Exhibits46: Chart on Immunosuppressants - Year-over-year growth 2024-2029 (%); Exhibits47: Data Table on Immunosuppressants - Year-over-year growth 2024-2029 (%); Exhibits48: Chart on Anti-infectives - Market size and forecast 2024-2029 ($ million); Exhibits49: Data Table on Anti-infectives - Market size and forecast 2024-2029 ($ million); Exhibits50: Chart on Anti-infectives - Year-over-year growth 2024-2029 (%); Exhibits51: Data Table on Anti-infectives - Year-over-year growth 2024-2029 (%); Exhibits52: Chart on Analgesics - Market size and forecast 2024-2029 ($ million); Exhibits53: Data Table on Analgesics - Market size and forecast 2024-2029 ($ million); Exhibits54: Chart on Analgesics - Year-over-year growth 2024-2029 (%); Exhibits55: Data Table on Analgesics - Year-over-year growth 2024-2029 (%); Exhibits56: Chart on Others - Market size and forecast 2024-2029 ($ million); Exhibits57: Data Table on Others - Market size and forecast 2024-2029 ($ million); Exhibits58: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits59: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits60: Market opportunity by Drug Class ($ million); Exhibits61: Data Table on Market opportunity by Drug Class ($ million); Exhibits62: Chart on Distribution Channel - Market share 2024-2029 (%); Exhibits63: Data Table on Distribution Channel - Market share 2024-2029 (%); Exhibits64: Chart on Comparison by Distribution Channel; Exhibits65: Data Table on Comparison by Distribution Channel; Exhibits66: Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million); Exhibits67: Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million); Exhibits68: Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%); Exhibits69: Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%); Exhibits70: Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million); Exhibits71: Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million); Exhibits72: Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%); Exhibits73: Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%); Exhibits74: Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million); Exhibits75: Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million); Exhibits76: Chart on Online pharmacies - Year-over-year growth 2024-2029 (%); Exhibits77: Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%); Exhibits78: Market opportunity by Distribution Channel ($ million); Exhibits79: Data Table on Market opportunity by Distribution Channel ($ million); Exhibits80: Chart on Type - Market share 2024-2029 (%); Exhibits81: Data Table on Type - Market share 2024-2029 (%); Exhibits82: Chart on Comparison by Type; Exhibits83: Data Table on Comparison by Type; Exhibits84: Chart on Left ventricular assist device (LVAD) - Market size and forecast 2024-2029 ($ million); Exhibits85: Data Table on Left ventricular assist device (LVAD) - Market size and forecast 2024-2029 ($ million); Exhibits86: Chart on Left ventricular assist device (LVAD) - Year-over-year growth 2024-2029 (%); Exhibits87: Data Table on Left ventricular assist device (LVAD) - Year-over-year growth 2024-2029 (%); Exhibits88: Chart on Heart transplantation - Market size and forecast 2024-2029 ($ million); Exhibits89: Data Table on Heart transplantation - Market size and forecast 2024-2029 ($ million); Exhibits90: Chart on Heart transplantation - Year-over-year growth 2024-2029 (%); Exhibits91: Data Table on Heart transplantation - Year-over-year growth 2024-2029 (%); Exhibits92: Chart on Implantable cardiac defibrillator (ICD) - Market size and forecast 2024-2029 ($ million); Exhibits93: Data Table on Implantable cardiac defibrillator (ICD) - Market size and forecast 2024-2029 ($ million); Exhibits94: Chart on Implantable cardiac defibrillator (ICD) - Year-over-year growth 2024-2029 (%); Exhibits95: Data Table on Implantable cardiac defibrillator (ICD) - Year-over-year growth 2024-2029 (%); Exhibits96: Chart on Extracorporeal membrane oxygenation (ECMO) - Market size and forecast 2024-2029 ($ million); Exhibits97: Data Table on Extracorporeal membrane oxygenation (ECMO) - Market size and forecast 2024-2029 ($ million); Exhibits98: Chart on Extracorporeal membrane oxygenation (ECMO) - Year-over-year growth 2024-2029 (%); Exhibits99: Data Table on Extracorporeal membrane oxygenation (ECMO) - Year-over-year growth 2024-2029 (%); Exhibits100: Market opportunity by Type ($ million); Exhibits101: Data Table on Market opportunity by Type ($ million); Exhibits102: Chart on Indication - Market share 2024-2029 (%); Exhibits103: Data Table on Indication - Market share 2024-2029 (%); Exhibits104: Chart on Comparison by Indication; Exhibits105: Data Table on Comparison by Indication; Exhibits106: Chart on Ischemic heart disease (IHD) - Market size and forecast 2024-2029 ($ million); Exhibits107: Data Table on Ischemic heart disease (IHD) - Market size and forecast 2024-2029 ($ million); Exhibits108: Chart on Ischemic heart disease (IHD) - Year-over-year growth 2024-2029 (%); Exhibits109: Data Table on Ischemic heart disease (IHD) - Year-over-year growth 2024-2029 (%); Exhibits110: Chart on Dilated cardiomyopathy (DCM) - Market size and forecast 2024-2029 ($ million); Exhibits111: Data Table on Dilated cardiomyopathy (DCM) - Market size and forecast 2024-2029 ($ million); Exhibits112: Chart on Dilated cardiomyopathy (DCM) - Year-over-year growth 2024-2029 (%)